Staar Surgical (STAA) Cost of Revenue (2010 - 2026)

Staar Surgical's Cost of Revenue history runs 17 years deep, the most recent figure standing at $24.7 million for Q2 2026.

• Quarterly Cost of Revenue rose 69.11% year-over-year to $24.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $67.1 million (down 7.55% YoY) and the FY2026 annual result came in at $57.0 million, down 23.27% from the prior year.
• Cost of Revenue was $24.7 million for Q2 2026 at Staar Surgical, up from $14.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $24.7 million in Q2 2026 and bottomed at $11.5 million in Q2 2025.
• A 5-year average of $16.9 million and a median of $16.3 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2025 — Cost of Revenue slumped 44.05% — and 2026, when it soared 69.11%.
• Staar Surgical's Cost of Revenue stood at $14.3 million in 2022, then increased by 9.04% to $15.5 million in 2023, then advanced by 11.28% to $17.3 million in 2024, then slipped by 2.57% to $16.9 million in 2025, then soared by 46.31% to $24.7 million in 2026.
• Business Quant data shows STAA's Cost of Revenue at $24.7 million in Q2 2026, $14.1 million in Q1 2026, and $16.9 million in Q3 2025.